CA2976109C - Pyrrolopyrimidine substituee, pyrazolopyrimidine et derives de purine, et utilisation connexe comme inhibiteurs de lrrk2 - Google Patents

Pyrrolopyrimidine substituee, pyrazolopyrimidine et derives de purine, et utilisation connexe comme inhibiteurs de lrrk2

Info

Publication number
CA2976109C
CA2976109C CA2976109A CA2976109A CA2976109C CA 2976109 C CA2976109 C CA 2976109C CA 2976109 A CA2976109 A CA 2976109A CA 2976109 A CA2976109 A CA 2976109A CA 2976109 C CA2976109 C CA 2976109C
Authority
CA
Canada
Prior art keywords
compound
substituted
img
butyl
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA2976109A
Other languages
English (en)
Other versions
CA2976109A1 (fr
Inventor
Nathanael S. Gray
John Hatcher
Hwan Geun Choi
Original Assignee
Dana Farber Cancer Institute Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dana Farber Cancer Institute Inc filed Critical Dana Farber Cancer Institute Inc
Priority claimed from PCT/US2016/017754 external-priority patent/WO2016130920A2/fr
Publication of CA2976109A1 publication Critical patent/CA2976109A1/fr
Application granted granted Critical
Publication of CA2976109C publication Critical patent/CA2976109C/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

Il est décrit des composés ayant la formule I. Les composés de la présente divulgation sont utiles pour le traitement de maladies neurodégénératives, comme la maladie de Parkinson.
CA2976109A 2015-02-13 2016-02-12 Pyrrolopyrimidine substituee, pyrazolopyrimidine et derives de purine, et utilisation connexe comme inhibiteurs de lrrk2 Active CA2976109C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562116038P 2015-02-13 2015-02-13
US62/116,038 2015-02-13
PCT/US2016/017754 WO2016130920A2 (fr) 2015-02-13 2016-02-12 Inhibiteurs de lrrk2 et leurs méthodes de production et d'utilisation

Publications (2)

Publication Number Publication Date
CA2976109A1 CA2976109A1 (fr) 2016-08-18
CA2976109C true CA2976109C (fr) 2025-07-15

Family

ID=

Similar Documents

Publication Publication Date Title
US20210115055A1 (en) Lrrk2 inhibitors and methods of making and using the same
JP6553772B2 (ja) ピリミド−ジアゼピノン化合物および障害の治療方法
KR101920456B1 (ko) 신규한 이미다조피리딘 유도체, 이의 제조방법 및 이를 유효성분으로 함유하는 암의 예방 또는 치료용 약학적 조성물
US11208412B2 (en) Pyrrolo-pyrimidine derivative compound, preparation method therefor, and pharmaceutical composition comprising same compound as effective ingredient for preventing or treating protein kinase-related disease
CA2954187C (fr) Inhibiteurs de kinase macrocycliques et leurs utilisations
US10266537B2 (en) 3-acetylenyl-pyrazole-pyrimidine derivative, and preparation method therefor and uses thereof
KR101896568B1 (ko) 피롤로-피리딘 유도체 화합물, 이의 제조방법 및 이를 유효성분으로 함유하는 단백질 키나아제 관련 질환의 예방 또는 치료용 약학적 조성물
EP3965803B1 (fr) Inhibiteurs de kinase d'adhésion focale à petites molécules (fak)
KR20200020622A (ko) 치환된 헤테로아릴 유도체, 이의 제조방법 및 이를 유효성분으로 함유하는 단백질 키나아제 관련 질환의 예방 또는 치료용 약학적 조성물
EP3440084B1 (fr) Composés pyrimido-diazépinone d'échafaudage de kinase et procédés de traitement de troubles induits par pi3k
KR20180017549A (ko) 단백질 키나아제 저해 활성을 갖는 3,4-다이하이드로피리미도[4,5-d]피리미딘-2(1H)-온 골격의 유레아 화합물
KR102328435B1 (ko) 신규 피리도-피리미딘 유도체, 이의 제조방법 및 이를 유효성분으로 함유하는 단백질 키나아제 관련 질환의 예방 또는 치료용 약학적 조성물
CA2976109C (fr) Pyrrolopyrimidine substituee, pyrazolopyrimidine et derives de purine, et utilisation connexe comme inhibiteurs de lrrk2
HK40044616A (en) Lrrk2 inhibitors and methods of making and using the same
HK40045412A (en) Lrrk2 inhibitors and methods of making and using the same
KR102328423B1 (ko) 신규 트리아졸로-피리미딘 유도체, 이의 제조방법 및 이를 유효성분으로 함유하는 단백질 키나아제 관련 질환의 예방 또는 치료용 약학적 조성물
KR102286701B1 (ko) 피리도[2,3-d]피리미딘 유도체, 이의 제조방법 및 이를 유효성분으로 포함하는 암의 예방 또는 치료용 약학적 조성물
TW202606701A (zh) 甲醯胺化合物
EP4722212A1 (fr) Nouveau composé pour inhiber des protéines kinases et composition pharmaceutique le comprenant